---
title: "14:55 ETAre XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285107937.md"
description: "Halper Sadeh LLC is investigating XOMA, RMAX, and KALV for potential violations of federal securities laws and breaches of fiduciary duties to shareholders. The firm is concerned that insiders may benefit financially from proposed transactions that could limit competing offers. Shareholders are encouraged to contact the firm for their rights and options regarding XOMA's sale to Ligand Pharmaceuticals, RMAX's sale to The Real Brokerage, and KALV's sale to Chiesi Group. Halper Sadeh LLC aims to seek increased consideration and other benefits for shareholders."
datetime: "2026-05-04T18:55:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285107937.md)
  - [en](https://longbridge.com/en/news/285107937.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285107937.md)
---

# 14:55 ETAre XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?

**_Insiders may stand to receive substantial financial benefits not available to ordinary shareholders._**

**_The proposed transactions may contain terms that could limit superior competing offers._**

**_Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses._**

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

**XOMA Royalty Corporation (NASDAQ: XOMA)'s** sale to Ligand Pharmaceuticals Incorporated for $39.00 per share. **If you are a XOMA shareholder,** **click here to learn more about your rights and options****.**

**RE/MAX Holdings, Inc. (NYSE: RMAX)'s** sale to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in cash per share. **If you are a RE/MAX shareholder,** **click here to learn more about your rights and options****.**

**KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)'s** sale to Chiesi Group for $27.00 per share in cash. **If you are a KalVista shareholder,** **click here to learn more about your legal rights and options**.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:  
Halper Sadeh LLC  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
One World Trade Center  
85th Floor  
New York, NY 10007  
(212) 763-0060  
\[email protected\]  
\[email protected\]  
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

### Related Stocks

- [RMAX.US](https://longbridge.com/en/quote/RMAX.US.md)
- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)
- [REAX.US](https://longbridge.com/en/quote/REAX.US.md)
- [XOMA.US](https://longbridge.com/en/quote/XOMA.US.md)
- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)
- [XOMAP.US](https://longbridge.com/en/quote/XOMAP.US.md)
- [XOMAO.US](https://longbridge.com/en/quote/XOMAO.US.md)

## Related News & Research

- [District Announces Promising Water Treatment Results from Collaboration with Xoma AB | DMXCF Stock News](https://longbridge.com/en/news/286861678.md)
- [Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks](https://longbridge.com/en/news/286635514.md)
- [Ligand Pharmaceuticals Amends XOMA Royalty Merger Agreement to Add Holding Company](https://longbridge.com/en/news/286776618.md)
- [17:25 ETAre XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/286471428.md)
- [Full Transcript: DRI HEALTHCARE TRUST Q1 2026 Earnings Call](https://longbridge.com/en/news/286578500.md)